HAEMONETICS CORP 8-K

What Happened

• Haemonetics Corporation (HAE) filed a Form 8‑K on February 5, 2026 (Item 2.02) to announce its financial results for the third quarter and the nine months ended December 27, 2025. The company furnished a press release with the results.

Key Details

• Filing date: February 5, 2026.
• Reporting period: third quarter and nine months ended December 27, 2025.
• Disclosure method: press release furnished as Exhibit 99.1 to the Form 8‑K; interactive XBRL cover page provided as Exhibit 104.
• Form 8‑K signed by Christopher A. Simon, President and Chief Executive Officer.

Why It Matters

• The 8‑K signals Haemonetics has publicly released its latest quarterly and year‑to‑date financial results; investors should review the attached press release for revenue, earnings (EPS), segment performance, and any commentary on trends or outlook.
• Quarterly results can affect near‑term valuation and investor expectations for HAE; this filing is the official source for the company's reported Q3 and nine‑month performance.